{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:44:19Z","timestamp":1782737059249,"version":"3.54.5"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11095-022-03441-5","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T21:30:31Z","timestamp":1669843831000},"page":"593-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Advanced Solid Formulations For Vulvovaginal Candidiasis"],"prefix":"10.1007","volume":"40","author":[{"given":"J\u00falia","family":"Conte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Luis","family":"Parize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-6310","authenticated-orcid":false,"given":"Thiago","family":"Caon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"3441_CR1","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","volume":"369","author":"JD Sobel","year":"2007","unstructured":"Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961\u201371.","journal-title":"Lancet"},{"key":"3441_CR2","first-page":"1","volume":"3","author":"MA Farage","year":"2010","unstructured":"Farage MA, Miller KW, Sobel JD. Dynamics of the vaginal ecosystem-hormonal influences. Infectious Diseases: Research and Treatment. 2010;3:1\u201315.","journal-title":"Infectious Diseases: Research and Treatment"},{"key":"3441_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","volume":"42","author":"B Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42:905\u201327.","journal-title":"Crit Rev Microbiol"},{"key":"3441_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3109\/10717544.2014.928760","volume":"23","author":"HS Johal","year":"2016","unstructured":"Johal HS, Garg T, Rath G, Goyal AK. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Delivery. 2016;23:550\u201363.","journal-title":"Drug Delivery"},{"key":"3441_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","volume":"214","author":"JD Sobel","year":"2016","unstructured":"Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214:15\u201321. https:\/\/doi.org\/10.1016\/j.ajog.2015.06.067.","journal-title":"Am J Obstet Gynecol"},{"key":"3441_CR6","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","volume":"18","author":"DW Denning","year":"2018","unstructured":"Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18:e339\u201347. https:\/\/doi.org\/10.1016\/S1473-3099(18)30103-8.","journal-title":"Lancet Infect Dis"},{"key":"3441_CR7","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.4103\/0366-6999.181964","volume":"129","author":"FJ Wang","year":"2016","unstructured":"Wang FJ, Zhang D, Liu ZH, Wu WX, Bai HH, Dong HY. Species distribution and in vitro antifungal susceptibility of vulvovaginal Candida isolates in China. Chin Med J. 2016;129:1161\u20135.","journal-title":"Chin Med J"},{"key":"3441_CR8","doi-asserted-by":"crossref","unstructured":"Sardi J de CO, Silva DR, Anibal PC, Baldin JJCM de C, Ramalho SR, Rosalen PL, et al. Vulvovaginal candidiasis: epidemiology and risk factors, pathogenesis, resistance, and new therapeutic options. Current Fungal Infection Reports. 2021;15:32\u201340.","DOI":"10.1007\/s12281-021-00415-9"},{"key":"3441_CR9","doi-asserted-by":"crossref","unstructured":"Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends in Microbiology. 2001;9:327\u201335. Available from: http:\/\/tim.trends.com","DOI":"10.1016\/S0966-842X(01)02094-7"},{"key":"3441_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","volume":"62","author":"JCO Sardi","year":"2013","unstructured":"Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10\u201324.","journal-title":"J Med Microbiol"},{"key":"3441_CR11","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1128\/AAC.48.9.3291-3297.2004","volume":"48","author":"MA Al-Fattani","year":"2004","unstructured":"Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother. 2004;48:3291\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"3441_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1157\/13097528","volume":"126","author":"J Pont\u00f3n","year":"2006","unstructured":"Pont\u00f3n J, Quind\u00f3s G. Mechanisms of resistance to antifungal therapy. Med Clin. 2006;126:56\u201360. https:\/\/doi.org\/10.1157\/13097528.","journal-title":"Med Clin"},{"key":"3441_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9060312","volume":"9","author":"S Bhattacharya","year":"2020","unstructured":"Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and mechanisms of antifungal resistance. Antibiotics. 2020;9:1\u201319.","journal-title":"Antibiotics"},{"key":"3441_CR14","unstructured":"Soares D, Lima E, Soares D, Silva N, Costa N, Faria F, et al. Candid\u00edase vulvovaginal: uma revis\u00e3o de literatura com abordagem para Candida albicans. 2018;25:28\u201334."},{"key":"3441_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15570\/actaapa.2015.2","volume":"24","author":"A Dovnik","year":"2015","unstructured":"Dovnik A, Golle A, Novak D, Arko D, Taka\u010d I. Treatment of vulvovaginal candidiasis: A review of the literature. Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 2015;24:5\u20137.","journal-title":"Acta Dermatovenerologica Alpina, Pannonica et Adriatica"},{"key":"3441_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2015","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2015;62:e1-50.","journal-title":"Clin Infect Dis"},{"key":"3441_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7555\/JBR.27.20120136","volume":"28","author":"RM Gilhotra","year":"2014","unstructured":"Gilhotra RM, Ikram M, Srivastava S, Gilhotra N. A clinical perspective on mucoadhesive buccal drug delivery systems. J Biomed Res. 2014;28:81\u201397.","journal-title":"J Biomed Res"},{"key":"3441_CR18","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.biopha.2017.11.127","volume":"96","author":"B Sawant","year":"2017","unstructured":"Sawant B, Khan T. Recent advances in delivery of antifungal agents for therapeutic management of candidiasis. Biomed Pharmacother. 2017;96:1478\u201390. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.127.","journal-title":"Biomed Pharmacother"},{"key":"3441_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpharm.2018.12.011","volume":"556","author":"NL Calvo","year":"2019","unstructured":"Calvo NL, Svetaz LA, Alvarez VA, Quiroga AD, Lamas MC, Leonardi D. Chitosan-hydroxypropyl methylcellulose tioconazole films: a promising alternative dosage form for the treatment of vaginal candidiasis. Int J Pharm. 2019;556:181\u201391. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.12.011.","journal-title":"Int J Pharm"},{"key":"3441_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.msec.2020.110635","volume":"110","author":"N Nematpour","year":"2020","unstructured":"Nematpour N, Moradipour P, Zangeneh MM, Arkan E, Abdoli M, Behbood L. The application of nanomaterial science in the formulation a novel antibiotic: assessment of the antifungal properties of mucoadhesive clotrimazole loaded nanofiber versus vaginal films. Mater Sci Eng, C. 2020;110:1\u201312. https:\/\/doi.org\/10.1016\/j.msec.2020.110635.","journal-title":"Mater Sci Eng, C"},{"key":"3441_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.addr.2015.02.003","volume":"92","author":"RM Machado","year":"2015","unstructured":"Machado RM, Palmeira-de-oliveira A, Gaspar C, Martinez-de-oliveira J, Palmeira-de-oliveira R. Studies and methodologies on vaginal drug permeation. Adv Drug Deliv Rev. 2015;92:14\u201326. https:\/\/doi.org\/10.1016\/j.addr.2015.02.003.","journal-title":"Adv Drug Deliv Rev"},{"key":"3441_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","volume":"103","author":"A Hussain","year":"2005","unstructured":"Hussain A, Ahsan F. The vagina as a route for systemic drug delivery. J Control Release. 2005;103:301\u201313.","journal-title":"J Control Release"},{"key":"3441_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2016.09.020","volume":"243","author":"C Cunha-Reis","year":"2016","unstructured":"Cunha-Reis C, Machado A, Barreiros L, Ara\u00fajo F, Nunes R, Seabra V, et al. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs. J Control Release. 2016;243:43\u201353. https:\/\/doi.org\/10.1016\/j.jconrel.2016.09.020.","journal-title":"J Control Release"},{"key":"3441_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics11030145","volume":"11","author":"L Mesquita","year":"2019","unstructured":"Mesquita L, Galante J, Nunes R, Sarmento B, Neves J. Pharmaceutical vehicles for vaginal and rectal administration of anti-HIV microbicide nanosystems. Pharmaceutics. 2019;11:1\u201320.","journal-title":"Pharmaceutics"},{"key":"3441_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.0105-2896.2005.00287.x","volume":"206","author":"CR Wira","year":"2005","unstructured":"Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female genital tract: Cellular responses and interactions. Immunol Rev. 2005;206:306\u201335.","journal-title":"Immunol Rev"},{"key":"3441_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.micro.55.1.743","volume":"55","author":"JH van Burik","year":"2001","unstructured":"van Burik JH, Magee PT. Aspects of fungal pathogenesis in humans. Annual Review of Microbiolog. 2001;55:743\u201372.","journal-title":"Annual Review of Microbiolog"},{"key":"3441_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","volume":"36","author":"S Silva","year":"2012","unstructured":"Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36:288\u2013305.","journal-title":"FEMS Microbiol Rev"},{"key":"3441_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1004257","volume":"10","author":"JR Naglik","year":"2014","unstructured":"Naglik JR, Richardson JP, Moyes DL. Candida albicans pathogenicity and epithelial immunity. PLoS Pathog. 2014;10:1\u20134.","journal-title":"PLoS Pathog"},{"key":"3441_CR29","doi-asserted-by":"publisher","unstructured":"Pavithra D, Doble M. Biofilm formation, bacterial adhesion and host response on polymeric implants - issues and prevention. Biomedical Materials. 2008;3:034003.\u00a0https:\/\/doi.org\/10.1088\/1748-6041\/3\/3\/034003","DOI":"10.1088\/1748-6041\/3\/3\/034003"},{"key":"3441_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev.micro.56.012302.160705","volume":"56","author":"P Stoodley","year":"2002","unstructured":"Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol. 2002;56:187\u2013209.","journal-title":"Annu Rev Microbiol"},{"key":"3441_CR31","doi-asserted-by":"publisher","unstructured":"Krishnasamy L, Rubini D, Senthilganesh J, Saikumar C, Kumaramanickavel G, Aruni AW, et al. Phylogenetic characterization of biofilm forming multidrug resistant Candida albicans and non albicans Candida causing vulvovaginal candidiasis. Gene Reports. 2020;19. https:\/\/doi.org\/10.1016\/j.genrep.2020.100644","DOI":"10.1016\/j.genrep.2020.100644"},{"key":"3441_CR32","first-page":"78","volume":"11","author":"LC Rohan","year":"2009","unstructured":"Rohan LC, Sassi AB. Vaginal drug delivery systems for HIV prevention. American Association of Pharmaceutical Scientists. 2009;11:78\u201387.","journal-title":"American Association of Pharmaceutical Scientists"},{"key":"3441_CR33","first-page":"312","volume":"12","author":"E Baloglu","year":"2009","unstructured":"Baloglu E, Senyigit ZA, Karavana SY, Bernkop-schn\u00fcrch A. Strategies to prolong the intravaginal residence time of drug delivery systems. J Pharm Pharmaceut Sci. 2009;12:312\u201336.","journal-title":"J Pharm Pharmaceut Sci"},{"key":"3441_CR34","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.addr.2005.07.004","volume":"57","author":"C Valenta","year":"2005","unstructured":"Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev. 2005;57:1692\u2013712.","journal-title":"Adv Drug Deliv Rev"},{"key":"3441_CR35","unstructured":"Graff V. Human Anatomy. Knowledge Creation Diffusion Utilization. 2001."},{"key":"3441_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/026119291103900403","volume":"39","author":"G Costin","year":"2011","unstructured":"Costin G, Raabe HA, Priston R, Evans E, Curren RD. Vaginal irritation models: the current status of available alternative and in vitro tests. Altern Lab Anim. 2011;39:317\u201337.","journal-title":"Altern Lab Anim"},{"key":"3441_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.molimm.2010.07.016","volume":"48","author":"R Bulla","year":"2010","unstructured":"Bulla R, de Seta F, Radillo O, Agostinis C, Durigutto P, Pellis V. Mannose-binding lectin is produced by vaginal epithelial cells and its level in the vaginal fluid is influenced by progesterone. Mol Immunol. 2010;48:281\u20136. https:\/\/doi.org\/10.1016\/j.molimm.2010.07.016.","journal-title":"Mol Immunol"},{"key":"3441_CR38","first-page":"1","volume":"1","author":"V Ashok","year":"2012","unstructured":"Ashok V, Kumar R, Murali D. A review on vaginal route as a systemic drug delivery. Critical Review in Pharmaceutical Sciences. 2012;1:1\u201319.","journal-title":"Critical Review in Pharmaceutical Sciences"},{"key":"3441_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","volume":"92","author":"CM Caramella","year":"2015","unstructured":"Caramella CM, Rossi S, Ferrari F, Bonferoni MC, Sandri G. Mucoadhesive and thermogelling systems for vaginal drug delivery. Adv Drug Deliv Rev. 2015;92:39\u201352. https:\/\/doi.org\/10.1016\/j.addr.2015.02.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"3441_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3109\/03639045.2011.623355","volume":"38","author":"RRDA Pereira","year":"2012","unstructured":"Pereira RRDA, Bruschi ML. Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 2012;38:643\u201352.","journal-title":"Drug Dev Ind Pharm"},{"key":"3441_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1872211313666190215141507","volume":"13","author":"Z Iqbal","year":"2019","unstructured":"Iqbal Z, Dilnawaz F. Nanocarriers for vaginal drug delivery. Recent Pat Drug Delivery Formulation. 2019;13:3\u201315.","journal-title":"Recent Pat Drug Delivery Formulation"},{"key":"3441_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1095\/biolreprod.110.090423","volume":"85","author":"CD Blaskewicz","year":"2011","unstructured":"Blaskewicz CD, Pudney J, Anderson DJ. Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol Reprod. 2011;85:97\u2013104.","journal-title":"Biol Reprod"},{"key":"3441_CR43","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/jps.20107","volume":"93","author":"AB Sassi","year":"2004","unstructured":"Sassi AB, McCullough KD, Cost MR, Hillier SL, Rohan LC. Permeability of tritiated water through human cervical and vaginal tissue. J Pharm Sci. 2004;93:2009\u201316.","journal-title":"J Pharm Sci"},{"key":"3441_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jps.21077","volume":"97","author":"CA Squier","year":"2008","unstructured":"Squier CA, Mantz MJ, Schlievert PM, Davis CC. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J Pharm Sci. 2008;97:9\u201321. https:\/\/doi.org\/10.1002\/jps.21077.","journal-title":"J Pharm Sci"},{"key":"3441_CR45","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1128\/AAC.00456-10","volume":"54","author":"Y Gali","year":"2010","unstructured":"Gali Y, Delezay O, Brouwers J, Addad N, Augustijns P, Bourlet T, et al. In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides. Antimicrob Agents Chemother. 2010;54:5105\u201314.","journal-title":"Antimicrob Agents Chemother"},{"key":"3441_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.msec.2020.110756","volume":"111","author":"HS Sofi","year":"2020","unstructured":"Sofi HS, Abdal-hay A, Ivanovski S, Zhang YS, Sheikh FA. Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: current status and future perspectives. Mater Sci Eng, C. 2020;111:1\u201320. https:\/\/doi.org\/10.1016\/j.msec.2020.110756.","journal-title":"Mater Sci Eng, C"},{"key":"3441_CR47","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1210\/jcem.86.9.7817","volume":"86","author":"GI Gorodeski","year":"2001","unstructured":"Gorodeski GI. Estrogen biphasic regulation of paracellular permeability of cultured human vaginal-cervical epithelia. J Clin Endocrinol Metab. 2001;86:4233\u201343.","journal-title":"J Clin Endocrinol Metab"},{"key":"3441_CR48","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2174\/1381612033391801","volume":"9","author":"G Gorodeski","year":"2003","unstructured":"Gorodeski G. Nitric oxide regulation of permeability in human cervical and vaginal epithelial cells and in human endothelial cells. Curr Pharm Des. 2003;9:411\u20138.","journal-title":"Curr Pharm Des"},{"key":"3441_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.addr.2015.06.008","volume":"92","author":"R Palmeira-de-Oliveira","year":"2015","unstructured":"Palmeira-de-Oliveira R, Palmeira-de-Oliveira A, Martinez-de-Oliveira J. New strategies for local treatment of vaginal infections. Adv Drug Deliv Rev. 2015;92:105\u201322. https:\/\/doi.org\/10.1016\/j.addr.2015.06.008.","journal-title":"Adv Drug Deliv Rev"},{"key":"3441_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12223-018-0652-x","volume":"64","author":"TC Felix","year":"2019","unstructured":"Felix TC, de Brito R\u00f6der DVD, dos Santos PR. Alternative and complementary therapies for vulvovaginal candidiasis. Folia Microbiologica Folia Microbiologica. 2019;64:133\u201341.","journal-title":"Folia Microbiologica Folia Microbiologica"},{"key":"3441_CR51","doi-asserted-by":"crossref","unstructured":"Dota KFD, Consolaro MEL, Svidzinski TIE, Bruschi ML. Antifungal activity of Brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis. Evidence-Based Complementary and Alternative Medicine. 2011;1\u20138.","DOI":"10.1093\/ecam\/neq029"},{"key":"3441_CR52","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2009.03.021","volume":"64","author":"Z Shahid","year":"2009","unstructured":"Shahid Z, Sobel JD. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy. Diagn Microbiol Infect Dis. 2009;64:354\u20136. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.03.021.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3441_CR53","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1067\/mob.2001.115116","volume":"185","author":"JD Sobel","year":"2001","unstructured":"Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, et al. Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol. 2001;185:363\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"3441_CR54","doi-asserted-by":"crossref","unstructured":"Souza RO, Henrique de Lima T, Or\u00e9fice RL, de Freitas Ara\u00fajo MG, de Lima Moura SA, Magalh\u00e3es JT, et al. Amphotericin B-loaded poly(lactic-co-glycolic acid) nanofibers: an alternative therapy scheme for local treatment of vulvovaginal candidiasis. Journal of Pharmaceutical Sciences. 2018;107:2674\u201385.","DOI":"10.1016\/j.xphs.2018.06.017"},{"key":"3441_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/pt0804109","volume":"8","author":"MA Alam","year":"2007","unstructured":"Alam MA, Ahmad FJ, Khan ZI, Khar RK, Ali M. Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections. AAPS PharmSciTech. 2007;8:1\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"3441_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0015-0282(16)37333-2","volume":"21","author":"DR Mishell","year":"1970","unstructured":"Mishell DR, Lumkin ME. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings. Fertil Steril. 1970;21:99\u2013103.","journal-title":"Fertil Steril"},{"key":"3441_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.118725","volume":"572","author":"NR Welsh","year":"2019","unstructured":"Welsh NR, Malcolm RK, Devlin B, Boyd P. Dapivirine-releasing vaginal rings produced by plastic freeforming additive manufacturing. Int J Pharm. 2019;572:1\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118725.","journal-title":"Int J Pharm"},{"key":"3441_CR58","doi-asserted-by":"publisher","unstructured":"Notario-P\u00e9rez F, Cazorla-Luna R, Mart\u00edn-Illana A, Galante J, Ruiz-Caro R, das Neves J, et al. Design, fabrication and characterisation of drug-loaded vaginal films: State-of-the-art. Journal of Controlled Release. 2020;327:477\u201399. https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.032.","DOI":"10.1016\/j.jconrel.2020.08.032"},{"key":"3441_CR59","doi-asserted-by":"crossref","unstructured":"Shaikh R, Raj Singh T, Garland M, Woolfson A, Donnelly R. Mucoadhesive drug delivery systems. Journal of Pharmacy and Bioallied Sciences. 2011. p. 89\u2013100.","DOI":"10.4103\/0975-7406.76478"},{"key":"3441_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijpharm.2018.01.036","volume":"539","author":"J Fu","year":"2018","unstructured":"Fu J, Yu X, Jin Y. 3D printing of vaginal rings with personalized shapes for controlled release of progesterone. Int J Pharm. 2018;539:75\u201382. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.01.036.","journal-title":"Int J Pharm"},{"key":"3441_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics11100538","volume":"11","author":"K Tietz","year":"2019","unstructured":"Tietz K, Klein S. In vitro methods for evaluating drug release of vaginal ring formulations- a critical review. Pharmaceutics. 2019;11:1\u201323.","journal-title":"Pharmaceutics"},{"key":"3441_CR62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijpharm.2017.06.076","volume":"529","author":"G Verstraete","year":"2017","unstructured":"Verstraete G, Vandenbussche L, Kasmi S, Nuhn L, Brouckaert D, van Renterghem J, et al. Thermoplastic polyurethane-based intravaginal rings for prophylaxis and treatment of (recurrent) bacterial vaginosis. Int J Pharm. 2017;529:218\u201326. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.06.076.","journal-title":"Int J Pharm"},{"key":"3441_CR63","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1055\/a-1369-9395","volume":"81","author":"F Rafiei","year":"2021","unstructured":"Rafiei F, Tabesh H, Farzad S, Farzaneh F, Rezaei M, Hosseinzade F, et al. Development of hormonal intravaginal rings: technology and challenges. Geburtshilfe Frauenheilkd. 2021;81:789\u2013806.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"3441_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.addr.2016.01.015","volume":"103","author":"RK Malcolm","year":"2016","unstructured":"Malcolm RK, Boyd PJ, McCoy CF, Murphy DJ. Microbicide vaginal rings: technological challenges and clinical development. Adv Drug Deliv Rev. 2016;103:33\u201356. https:\/\/doi.org\/10.1016\/j.addr.2016.01.015.","journal-title":"Adv Drug Deliv Rev"},{"key":"3441_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2021.120290","volume":"596","author":"M Tiboni","year":"2021","unstructured":"Tiboni M, Campana R, Frangipani E, Casettari L. 3D printed clotrimazole intravaginal ring for the treatment of recurrent vaginal candidiasis. Int J Pharm. 2021;596:1\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120290.","journal-title":"Int J Pharm"},{"key":"3441_CR66","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1002\/jps.24154","volume":"103","author":"M Gunawardana","year":"2014","unstructured":"Gunawardana M, Baum MM, Smith TJ, Moss JA. An intravaginal ring for the sustained delivery of antibodies. J Pharm Sci. 2014;103:3611\u201320.","journal-title":"J Pharm Sci"},{"key":"3441_CR67","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s13346-017-0385-4","volume":"7","author":"SK Patel","year":"2017","unstructured":"Patel SK, Rohan LC. On-demand microbicide products: design matters. Drug Deliv Transl Res. 2017;7:775\u201395.","journal-title":"Drug Deliv Transl Res"},{"key":"3441_CR68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.addr.2015.03.015","volume":"92","author":"SG Antimisiaris","year":"2015","unstructured":"Antimisiaris SG, Mourtas S. Recent advances on anti-HIV vaginal delivery systems development. Adv Drug Deliv Rev. 2015;92:123\u201345. https:\/\/doi.org\/10.1016\/j.addr.2015.03.015.","journal-title":"Adv Drug Deliv Rev"},{"key":"3441_CR69","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/17425247.2017.1270938","volume":"14","author":"J Neves","year":"2017","unstructured":"Neves J, Sarmento B. Antiretroviral drug-loaded nanoparticles-in-films: a new option for developing vaginal microbicides? Expert Opin Drug Deliv. 2017;14:449\u201352. https:\/\/doi.org\/10.1080\/17425247.2017.1270938.","journal-title":"Expert Opin Drug Deliv"},{"key":"3441_CR70","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijbiomac.2019.02.092","volume":"130","author":"A Jalil","year":"2019","unstructured":"Jalil A, Asim MH, Le NMN, Laffleur F, Matuszczak B, Tribus M, et al. S-protected gellan gum: decisive approach towards mucoadhesive antimicrobial vaginal films. Int J Biol Macromol. 2019;130:148\u201357.","journal-title":"Int J Biol Macromol"},{"key":"3441_CR71","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bpobgyn.2012.02.001","volume":"26","author":"ZF Rosenberg","year":"2012","unstructured":"Rosenberg ZF, Devlin B. Future strategies in microbicide development. Best Pract Res Clin Obstet Gynaecol. 2012;26:503\u201313. https:\/\/doi.org\/10.1016\/j.bpobgyn.2012.02.001.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3441_CR72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejpb.2015.07.018","volume":"96","author":"P Bassi","year":"2015","unstructured":"Bassi P, Kaur G. Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization. Eur J Pharm Biopharm. 2015;96:173\u201384. https:\/\/doi.org\/10.1016\/j.ejpb.2015.07.018.","journal-title":"Eur J Pharm Biopharm"},{"key":"3441_CR73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0010-7824(97)00097-8","volume":"56","author":"CK Mauck","year":"1997","unstructured":"Mauck CK, Baker JM, Barr SP, Abercrombie TJ, Archer DF. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9 postcoital testing and colposcopy. Contraception. 1997;56:89\u201396.","journal-title":"Contraception"},{"key":"3441_CR74","doi-asserted-by":"publisher","unstructured":"Notario-P\u00e9rez F, Mart\u00edn-Illana A, Cazorla-Luna R, Ruiz-Caro R, Bedoya LM, Pe\u00f1a J, et al. Development of mucoadhesive vaginal films based on HPMC and zein as novel formulations to prevent sexual transmission of HIV. International Journal of Pharmaceutics. 2019;570. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118643","DOI":"10.1016\/j.ijpharm.2019.118643"},{"key":"3441_CR75","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/jps.23577","volume":"102","author":"RM Machado","year":"2013","unstructured":"Machado RM, Palmeira-de-oliveira A, Martinez-de-oliveira J, Palmeira-de-oliveira R. Vaginal Films for Drug Delivery. J Pharm Sci. 2013;102:2069\u201381.","journal-title":"J Pharm Sci"},{"key":"3441_CR76","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsps.2015.06.003","volume":"25","author":"P Bassi","year":"2017","unstructured":"Bassi P, Kaur G. Polymeric films as a promising carrier for bioadhesive drug delivery: Development, characterization and optimization. Saudi Pharmaceutical Journal. 2017;25:32\u201343. https:\/\/doi.org\/10.1016\/j.jsps.2015.06.003.","journal-title":"Saudi Pharmaceutical Journal"},{"key":"3441_CR77","doi-asserted-by":"crossref","unstructured":"Real DA, Martinez M v., Frattini A, Soazo M, Luque AG, Biasoli MS, et al. Design, characterization, and in vitro evaluation of antifungal polymeric films. AAPS PharmSciTech. 2013;14:64\u201373.","DOI":"10.1208\/s12249-012-9894-0"},{"key":"3441_CR78","doi-asserted-by":"publisher","unstructured":"Dolci LS, Albertini B, di Filippo MF, Bonvicini F, Passerini N, Panzavolta S. Development and in vitro evaluation of mucoadhesive gelatin films for the vaginal delivery of econazole. International Journal of Pharmaceutics. 2020;591. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119979","DOI":"10.1016\/j.ijpharm.2020.119979"},{"key":"3441_CR79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/2230-973X.176487","volume":"6","author":"R Mishra","year":"2016","unstructured":"Mishra R, Joshi P, Mehta T. Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasis. International Journal of Pharmaceutical Investigation. 2016;6:47\u201355.","journal-title":"International Journal of Pharmaceutical Investigation"},{"key":"3441_CR80","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10973-017-6402-5","volume":"130","author":"R Mishra","year":"2017","unstructured":"Mishra R, Soni K, Mehta T. Mucoadhesive vaginal film of fluconazole using cross-linked chitosan and pectin: In vitro and in vivo study. J Therm Anal Calorim. 2017;130:1683\u201395.","journal-title":"J Therm Anal Calorim"},{"key":"3441_CR81","unstructured":"Kumar L, Reddy MS, Shirodkar RK, Pai GK, Krishna VT, Verma R. Preparation and Characterisation of fluconazole vaginal films for the treatment of vaginal candidiasis. Indian Journal of Pharmaceutical Sciences. 2013. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3877521\/"},{"key":"3441_CR82","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.colsurfb.2011.11.004","volume":"91","author":"I Ayensu","year":"2012","unstructured":"Ayensu I, Mitchell JC, Boateng JS. Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa. Colloids Surf, B. 2012;91:258\u201365.","journal-title":"Colloids Surf, B"},{"key":"3441_CR83","doi-asserted-by":"crossref","unstructured":"Ikeda T, Ikeda K, Yamamoto K, Ishizaki H, Yoshizawa Y, Yanagiguchi K, et al. Fabrication and characteristics of chitosan sponge as a tissue engineering scaffold. BioMed Research International. 2014;1\u20138.","DOI":"10.1155\/2014\/786892"},{"key":"3441_CR84","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/10837450.2010.531736","volume":"17","author":"S Rossi","year":"2012","unstructured":"Rossi S, Marciello M, Ferrari F, Puccio A, Bonferoni C, Sandri G, et al. Development of sponge-like dressings for mucosal\/transmucosal drug delivery into vaginal cavity. Pharm Dev Technol. 2012;17:219\u201326.","journal-title":"Pharm Dev Technol"},{"key":"3441_CR85","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s12221-016-6232-2","volume":"17","author":"Y Ge","year":"2016","unstructured":"Ge Y, Tang J. Fabrication, Characterization and antimicrobial property of natural TTOLs\/CS composite sponges. Fibers and Polymers. 2016;17:862\u201372.","journal-title":"Fibers and Polymers"},{"key":"3441_CR86","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jddst.2018.09.011","volume":"48","author":"DS Shaker","year":"2018","unstructured":"Shaker DS, Ismail S, Hamed S, El-Shishtawy EM. Butoconazole nitrate vaginal sponge: drug release and antifungal efficacy. Journal of Drug Delivery Science and Technology. 2018;48:274\u201387.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"3441_CR87","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejpb.2010.07.004","volume":"76","author":"A Aka-Any-Grah","year":"2010","unstructured":"Aka-Any-Grah A, Bouchemal K, Koffi A, Agnely F, Zhang M, Djabourov M, et al. Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids. Eur J Pharm Biopharm. 2010;76:296\u2013303. https:\/\/doi.org\/10.1016\/j.ejpb.2010.07.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"3441_CR88","doi-asserted-by":"crossref","unstructured":"Hammer KA, Carson CF, Riley T v. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. Journal of Antimicrobial Chemotherapy. 2004;53:1081\u20135.","DOI":"10.1093\/jac\/dkh243"},{"key":"3441_CR89","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/ptr.1348","volume":"18","author":"RS Farag","year":"2004","unstructured":"Farag RS, Shalaby AS, El-Baroty GA, Ibrahim NA, Ali MA, Hassan EM. Chemical and biological evaluation of the essential oils of different Melaleuca species. Phytother Res. 2004;18:30\u20135.","journal-title":"Phytother Res"},{"key":"3441_CR90","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/humupd\/dmu065","volume":"21","author":"VL Yarbrough","year":"2015","unstructured":"Yarbrough VL, Winkle S, Herbst-Kralovetz MM. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum Reprod Update. 2015;21:353\u201377.","journal-title":"Hum Reprod Update"},{"key":"3441_CR91","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.2174\/0929867328666201209095753","volume":"28","author":"E S\u00e1nchez-L\u00f3pez","year":"2021","unstructured":"S\u00e1nchez-L\u00f3pez E, G\u00f3mara MJ, Haro I. Nanotechnology-based platforms for vaginal delivery of peptide microbicides. Curr Med Chem. 2021;28:4356\u201379.","journal-title":"Curr Med Chem"},{"key":"3441_CR92","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/1061186X.2017.1331352","volume":"25","author":"M Mathur","year":"2017","unstructured":"Mathur M, Devi VK. Potential of novel drug delivery systems in the management of topical candidiasis. J Drug Target. 2017;25:685\u2013703. https:\/\/doi.org\/10.1080\/1061186X.2017.1331352.","journal-title":"J Drug Target"},{"key":"3441_CR93","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jddst.2017.11.008","volume":"43","author":"A Deepak","year":"2018","unstructured":"Deepak A, Goyal AK, Rath G. Nanofiber in transmucosal drug delivery. Journal of Drug Delivery Science and Technology. 2018;43:379\u201387.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"3441_CR94","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.msec.2018.10.069","volume":"94","author":"HS Sofi","year":"2019","unstructured":"Sofi HS, Ashraf R, Khan AH, Beigh MA, Majeed S, Sheikh FA. Reconstructing nanofibers from natural polymers using surface functionalization approaches for applications in tissue engineering, drug delivery and biosensing devices. Mater Sci Eng, C. 2019;94:1102\u201324.","journal-title":"Mater Sci Eng, C"},{"key":"3441_CR95","doi-asserted-by":"crossref","unstructured":"Pillay V, Dott C, Choonara YE, Tyagi C, Tomar L, Kumar P, et al. A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications. Journal of Nanomaterials. 2013;1\u201322.","DOI":"10.1155\/2013\/789289"},{"key":"3441_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics13020286","volume":"13","author":"S Omer","year":"2021","unstructured":"Omer S, Forg\u00e1ch L, Zelk\u00f3 R, Sebe I. Scale-up of electrospinning: Market overview of products and devices for pharmaceutical and biomedical purposes. Pharmaceutics. 2021;13:1\u201321.","journal-title":"Pharmaceutics"},{"key":"3441_CR97","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/01932690903223948","volume":"31","author":"DG Yu","year":"2010","unstructured":"Yu DG, Branford-White C, Shen XX, Zhang XF, Zhu LM. Solid dispersions of ketoprofen in drug-loaded electrospun nanofibers. J Dispersion Sci Technol. 2010;31:902\u20138.","journal-title":"J Dispersion Sci Technol"},{"key":"3441_CR98","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpharm.2014.06.059","volume":"473","author":"M Rasekh","year":"2014","unstructured":"Rasekh M, Karavasili C, Soong YL, Bouropoulos N, Morris M, Armitage D, et al. Electrospun PVP-indomethacin constituents for transdermal dressings and drug delivery devices. Int J Pharm. 2014;473:95\u2013104. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.06.059.","journal-title":"Int J Pharm"},{"key":"3441_CR99","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3109\/21691401.2014.966194","volume":"44","author":"R Sharma","year":"2016","unstructured":"Sharma R, Garg T, Goyal AK, Rath G. Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis. Artificial Cells, Nanomedicine and Biotechnology. 2016;44:524\u201331.","journal-title":"Artificial Cells, Nanomedicine and Biotechnology"},{"key":"3441_CR100","doi-asserted-by":"crossref","unstructured":"Tu\u011fcu-Demir\u00f6z F, Saar S, Kara AA, Y\u0131ld\u0131z A, Tun\u00e7el E, Acart\u00fcrk F. Development and characterization of chitosan nanoparticles loaded nanofiber hybrid system for vaginal controlled release of benzydamine. European Journal of Pharmaceutical Sciences. 2021;161.","DOI":"10.1016\/j.ejps.2021.105801"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-022-03441-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:24:36Z","timestamp":1677018276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-022-03441-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3441"],"URL":"https:\/\/doi.org\/10.1007\/s11095-022-03441-5","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}